Standard: Human gastric cancer organoids
- PMID: 39729207
- PMCID: PMC11680512
- DOI: 10.1186/s13619-024-00217-7
Standard: Human gastric cancer organoids
Abstract
Gastric cancer is one of the most common malignancies with poor prognosis. The use of organoids to simulate gastric cancer has rapidly developed over the past several years. Patient-derived gastric cancer organoids serve as in vitro models that closely mimics donor characteristics, offering new opportunities for both basic and applied research. The "Human Gastric Cancer Organoid" is part of a series of guidelines for human gastric cancer organoids in China, jointly drafted by experts from the Chinese Society for Cell Biology and its branches, and initially released on October 29, 2024. This standard outlines terminology, technical requirements, assessment protocols, and applies to production, evaluation procedures, and quality control for human gastric cancer organoids. The publication of this guideline aims to assist institutions in endorsing, establishing, and applying best practices, advancing the international standardization of human gastric cancer organoids for clinical development and therapeutic application.
Keywords: Definitions; Gastric cancer organoids; Human stomach; Labeling; Standard; Storage; Technical requirements; Terms; Transportation.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: Y.-G.C. is the Editor‑in‑Chief of Cell Regeneration. He was not involved in the review or decision related to this manuscript. This work was not sponsored by any commercial organizations, and all the other authors declare that they have no competing interests.
References
-
- Clevers H. Modeling Development and Disease with Organoids. Cell. 2016;165(7):1586–97. 10.1016/j.cell.2016.05.082. - PubMed
-
- Fujii M, Sato T. Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases. Nat Mater. 2021;20(2):156–69. 10.1038/s41563-020-0754-0. - PubMed
-
- Fujii M, Clevers H, Sato T. Modeling Human Digestive Diseases With CRISPR-Cas9–Modified Organoids. Gastroenterology. 2019;156(3):562–76. 10.1053/j.gastro.2018.11.048. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous